Attributable risk for radiation in the presence of other risk factors

Health Physics

Volumn 99, Issue 5, 2010, Pages 603-612

  Cologne, John ^a   Cullings, Harry ^b   Furukawa, Kyoji ^b   Ross, Phillip ^a  

^a RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^b NONE

Author keywords

atomic bomb survivors; cancer; health effects; risk analysis

Indexed keywords

BIOLOGICAL MODEL; HUMAN; LIVER DISEASE; LUNG TUMOR; RADIATION INJURY; REVIEW; RISK FACTOR; SMOKING; VIROLOGY;

HUMANS; LIVER DISEASES; LUNG NEOPLASMS; MODELS, BIOLOGICAL; RADIATION INJURIES; RISK FACTORS; SMOKING;

EID: 77958475755     PISSN: 00179078     EISSN: None     Source Type: Journal    
DOI: 10.1097/HP.0b013e3181db29fd     Document Type: Review

References (53)

1. Akiba S. Interactive effects between radiation and other factors on cancer risk among A-bomb survivors\-an overview of RERF studies. J Radiat Res 32(Suppl):339-346; 1991.
2. Beyea J, Greenland S. The importance of specifying the underlying biologic model in estimating the probability of causation. Health Phys 76:269-274; 1999.
3. Bhatti P, Struewing JP, Alexander BH, Hauptmann M, Bowen L, Mateus-Pereira LH, Pineda MA, Simon SL, Weinstock RM, Rosenstein M, Stovall M, Preston DL, Linet MS, Doody MM, Sigurdson AJ. Polymorphisms in DNA repair genes, ionizing radiation exposure and risk of breast cancer in U.S. radiologic technologists. Int J Cancer 122:177-182; 2008.
4. Breslow NE, Chatterjee N. Design and analysis of two-phase studies with binary outcome applied to Wilms tumour. Appl Stat 48:457-468; 1999.
5. Breslow NE, Day NE. Statistical methods in cancer research. Volume II\-The design and analysis of cohort studies. Lyon: International Agency for Research on Cancer; 1987.
6. Cologne J, Langholz B. Selecting controls for assessing interaction in nested case-control studies. J Epidemiol 13:193-202; 2003.
7. Cologne JB, Preston DL. Impact of comparison group on cohort dose response regression: an example using risk estimation in atomic-bomb survivors. Health Phys 80:491-496; 2001.
8. Cologne J, Izumi S, Shimizu Y, Preston D. Effect of comparison group on inference about effect modification by demographic factors in cohort risk regression. Japan J Biomet 23:49-66; 2002.
9. Cologne JB, Pawel DJ, Sharp GB, Fujiwara S. Uncertainty in estimating probability of causation in a cross-sectional study: joint effects of radiation and hepatitis-C virus on chronic liver disease. J Radiol Prot 24:131-145; 2004a.
10. Cologne JB, Sharp GB, Neriishi K, Verkasalo PK, Land CE, Nakachi K. Improving the efficiency of nested case-control studies of interaction by selecting controls using counter matching on exposure. Int J Epidemiol 33:485-492; 2004b.
11. Cullings HM, Cologne JB. Risk from ionizing radiation. In: Melnick EL, Everitt BS, eds. Encyclopedia of quantitative risk analysis and assessment. Chichester: John Wiley & Sons, Ltd.; 2008: 1540-1546.
12. Enterline PE. Attributability in the face of uncertainty. Chest 78(Suppl):377-379; 1980.
13. Fujiwara S, Kusumi S, Cologne J, Akahoshi M, Kodama K, Yoshizawa H. Prevalence of anti-hepatitis C virus antibody and chronic liver disease among atomic bomb survivors. Radiat Res 154:12-19; 2000.
14. Furukawa K, Cologne JB, Shimizu Y, Ross NP. Predicting future excess events in risk assessment. Risk Anal 29:885-899; 2009.
15. Furukawa K, Preston DL, Lönn S, Funamoto S, Yonehara S, Matsuo T, Egawa H, Tokuoka S, Ozasa K, Kasagi F, Kodama K, Mabuchi K. Radiation and smoking effects on lung cancer incidence among atomic bomb survivors. Ra-diat Res 174:72-82; 2010.
16. Greenland S, Robins JM. Conceptual problems in the definition and interpretation of attributable fractions. Am J Epidemiol 128:1185-1197; 1988.
17. Harrell FE, Lee KL, Pollock BG. Regression models in clinical studies: determining relationships between predictors and response. JNCI 80:1198-1202; 1988.
18. Heidenreich WF, Cullings HM, Funamoto S, Paretzke HG. Promoting action of radiation in the atomic bomb survivor carcinogenesis data? Radiat Res 168:750-756; 2007.
19. Kai M, Luebeck EG, Moolgavkar SH. Analysis of the incidence of solid cancer among atomic bomb survivors using a two-stage model of carcinogenesis. Radiat Res 148:348-358; 1997.
20. Kocher DC, Apostoaei AI, Henshaw RW, Hoffman FO, Schubauer-Berigan MK, Stancescu DO, Thomas BA, Tra-balka JR, Gilbert ES, Land CE. Interactive radioepidemio-logical program (IREP): a Web-based tool for estimating probability of causation/assigned share of radiogenic cancers. Health Phys 95:119-147; 2008.
21. Lagakos SW, Mosteller F. Assigned shares in compensation for radiation-related cancers. Risk Anal 6:345-357; 1986.
22. Land CE, Hayakawa N, Machado SG, Yamada Y, Pike MC, Akiba S, Tokunaga M. A case-control interview study of breast cancer among Japanese A-bomb survivors. I. Main effects. Cancer Causes Control 5:157-165; 1994a.
23. Land CE, Hayakawa N, Machado SG, Yamada Y, Pike MC, Akiba S, Tokunaga M. A case-control interview study of breast cancer among Japanese A-bomb survivors. II. Interactions with radiation dose. Cancer Causes Control 5:167-176; 1994b.
24. Land C, Gilbert E, Smith JM. Report of the NCI-CDC working group to revise the 1985 NIH radioepidemiological tables. Washington, DC: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute; NIH 03-5387; 2003.
25. Langholz B, Borgan O. Counter-matching: a stratified nested case-control sampling method. Biometrika 82:69-79; 1995.
26. Langholz B, Goldstein L. Risk set sampling in epidemiologic cohort studies. Stat Sci 11:35-53; 1996.
27. Luebeck EG, Heidenreich WF, Hazelton WD, Paretzke HG, Moolgavkar SH. Biologically based analysis of the data for the Colorado uranium miners cohort: age, dose and dose-rate effects. Radiat Res 152:339-351; 1999.
28. Marshall SW. Power for tests of interaction: effect of raising the type I error rate [online]. Epidemiologic Perspectives & Innovations 4:4; 2007. Available at: http://www.epi-perspectives. com/content/4/1/4. Accessed 5 October 2009.
29. Millikan RC, Player JS, deCotret AR, Tse C-K, Keku T. Polymorphisms in DNA repair genes, medical exposure to ionizing radiation, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14:2326-2334; 2005.
30. National Institutes of Health. Interactive radioepidemiological program IREP v. 5.3 for estimating assigned share (probability of cancer causation) for exposures to radiation [online]. Bethesda, MD: NIH; 2006. Available at: http:// www.irep.nci.nih.gov/. Accessed 5 October 2009.
31. National Institute for Occupational Safety and Health. Interactive radioepidemiological program NIOSH-IREP v. 5.5.2 for estimating probability of cancer causation for exposures to radiation [online]. Atlanta, GA: NIOSH 2007. Available at: https://www.niosh-irep.com/irep-niosh/. Accessed 5 October 2009.
32. National Research Council. Health effects of exposure to radon: BEIR VI. Washington DC: National Academies Press. 1999.
33. National Research Council, Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation. Health risks from exposure to low levels of ionizing radiation: BEIR VII Phase 2. Washington, DC: The National Academies Press; 2006.
34. Pierce DA, Sharp GB, Mabuchi K. Joint effects of radiation and smoking on lung cancer risk among Atomic Bomb Survivors. Radiat Res 159:511-520; 2003.
35. Preston DL, Lubin JH, Pierce DA, McConney ME. Epicure user's guide. Seattle: Hirosoft International Corporation; 1993.
36. Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. Radiat Res 160:381-407; 2003.
37. Preston DL, Ron E, Tokuoka S, Funamoto S, Nishi N, Soda M, Mabuchi K, Kodama K. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res 168:1-64; 2007.
38. Robins J, Greenland S. The probability of causation under a stochastic model for individual risk. Biometrics 45:1125-1138; 1989a.
39. Robins JM, Greenland S. Estimability and estimation of excess and etiologic fractions. Stat Med 8:845-859; 1989b.
40. Robins J, Greenland S. Estimability and estimation of expected years of life lost due to a hazardous exposure. Stat Med 10:79-93; 1991.
41. Rothman KJ, Greenland S. Modern epidemiology. Philadelphia: Lippincott Williams & Wilkins; 1998.
42. Royston P, Altman DG. Regression using fractional polynomials of continuous covariates: Parsimonious parametric modelling. Appl Stat 43:429-467; 1994.
43. Seiler FA, Scott BR. Mixtures of toxic agents and attributable risk calculations. Risk Anal 7:81-90; 1987.
44. Sharp GB, Mizuno T, Cologne JB, Fukuyara T, Fujiwara S, Tokuoka S, Mabuchi K. Hepatocellular carcinoma among atomic bomb survivors: significant interaction of radiation with hepatitis C virus infections. Int J Cancer 103:531-537; 2003.
45. Sherman CD. Modeling cancer incidence in A-bomb survivors: a perspective. Stoch Env Res Risk Assess 13:48-65; 1999.
46. Shore RE, Woodard ED, Hempelmann LH, Pasternack BS. Synergism between radiation and other risk factors for breast cancer. Prev Med 9:815-822; 1980.
47. Sigurdson AJ, Bhatti P, Doody MM, Hauptmann M, Bowen L, Simon SL, Weinstock RM, Linet MS, Rosenstein M, Stovall M, Alexander BH, Preston DL, Struewing JP, Rajaraman P. Polymorphisms in apoptosis-and proliferation-related genes, ionizing radiation exposure, and risk of breast cancer among U.S. radiologic technologists. Cancer Epidemiol Biomarkers Prev 16:2000-2007; 2007.
48. Storer BE, Wacholder S, Breslow NE. Maximum likelihood fitting of general risk models to stratified data. Appl Stat 32:172-181; 1983.
49. Thomas DC. General relative-risk models for survival time and matched case-control analysis. Biometrics 37:673-686; 1981.
50. Thomas DC. Statistical methods in environmental epidemiology. Oxford: Oxford University Press; 2009.
51. Thomas D, Darby S, Fagnani F, Hubert P, Vaeth M, Weiss K. Definition and estimation of lifetime detriment from radiation exposures: principles and methods. Health Phys 63:259-272; 1992.
52. Weinberg CR, Wacholder S. The design and analysis of case-control studies with biased sampling. Biometrics 46:963-975; 1990.
53. Yamada M, Wong FL, Fujiwara S, Akahoshi M, Suzuki G. Noncancer disease incidence in atomic bomb survivors, 1958-1998. Radiat Res 161:622-632; 2004.